Med Care Price Transparency Trumps Antitrust Risk, FTC Told

Law360, Washington (March 21, 2014, 4:29 PM EDT) -- Health care industry stakeholders encouraged the Federal Trade Commission on Friday to promote greater price transparency among insurers and providers despite the potential for some anti-competitive behavior, saying the benefits outweigh the risks.

Although there may be some concerns that hospitals and other health care providers will engage in price collusion if the market becomes too transparent, several panelists at an FTC forum on health care competition issues said it would be easy for regulators to combat those issues and let consumers take advantage of additional pricing information.

“When we...
To view the full article, register now.